✦ LIBER ✦

Rilonacept (IL-1 Trap) Demonstrates Rapid Reduction Of Clinical Symptoms In Patients With Cryopyrin-Associated Periodic Syndromes (CAPS) In A Placebo-Controlled Trial

✍ Scribed by Cartwright, R.; Throne, M.; Nadler, D.; Mahony, M.; Weinstein, S.P.; Mellis, S.J.

Book ID: 119281739
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 45 KB
Volume: 123
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2008.12.553

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The First Placebo-Controlled Trial in Cr

The First Placebo-Controlled Trial in Cryopyrin-Associated Periodic Syndromes (CAPS): IL-1 Trap (rilonacept) Markedly Reduces Clinical and Laboratory Abnormalities in Patients with Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS)

✍ Hoffman, H.M.; Weinstein, S.P.; Amar, N.J.; Throne, M.L.; Boling, E.P.; Grimes, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Efficacy and safety of rilonacept (inter

Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies

✍ Hal M. Hoffman; Martin L. Throne; N. J. Amar; Mohamed Sebai; Alan J. Kivitz; Art 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 1 views

Durability of Response to Rilonacept (IL

Durability of Response to Rilonacept (IL-1 Trap) in a Phase 3 Study of Patients with Cryopyrin-Associated Periodic Syndromes (CAPS): Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS)

✍ HOFFMAN, H; AMAR, N; CARTWRIGHT, R; KIVITZ, A; BELOMESTNOV, P; MELLIS, S; WEINST 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB